Endothelial progenitor cells predict long-term mortality in hemodialysis patients

Chien Lin Lu, Jyh Gang Leu, Wen Chih Liu, Cai Mei Zheng, Yuh Feng Lin, Jia Fwu Shyu, Chia Chao Wu, Kuo Cheng Lu

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: The endothelial progenitor cells (EPCs) dysfunction is a critical event in the initiation of atherosclerotic plaque development and the level of circulating EPCs can be considered a biomarker of cardiovascular events. The level and functional change in EPCs has been investigated in hemodialysis patients, but the effect of absolute number of EPCs on risk of death has not yet been explored. We hypothesized that the number of EPCs predicted death from cardiovascular and all-cause mortality in hemodialysis patients. Methods: We evaluate the association between endothelial progenitor cells and clinical outcome in 154 patients on maintenance hemodialysis. The blood sample was drawn at the time of patient enrollment and EPCs were identified by flow cytometry using triple staining for CD34/CD133/KDR. Results: The median duration of follow-up was 4.19 years. There were 79 (51.3%) deaths during the follow-up period, 41 of whom died due to a confirmed cardiovascular cause. The cumulative survival was greater in the high-EPC group than the low-EPC group for all-cause and cardiovascular mortality. Decreased EPCs levels were associated with a significant increase in the risk of cardiovascular and all-cause mortality after adjusting for age, gender, current smokers, diabetes mellitus, and hypertension. Conclusions: The level of circulating EPCs independently predicts the clinical outcome in patients on maintenance hemodialysis. Thus, the EPCs levels may be a useful predictive tool for evaluating the risk of death in maintenance hemodialysis patients.

Original languageEnglish
Pages (from-to)240-247
Number of pages8
JournalInternational Journal of Medical Sciences
Volume13
Issue number3
DOIs
Publication statusPublished - Feb 20 2016

Fingerprint

Renal Dialysis
Mortality
Maintenance
Endothelial Progenitor Cells
Atherosclerotic Plaques
Diabetes Mellitus
Flow Cytometry
Cell Death
Biomarkers
Staining and Labeling
Hypertension
Survival

Keywords

  • Endothelial progenitor cells
  • Hemodialysis
  • Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Endothelial progenitor cells predict long-term mortality in hemodialysis patients. / Lu, Chien Lin; Leu, Jyh Gang; Liu, Wen Chih; Zheng, Cai Mei; Lin, Yuh Feng; Shyu, Jia Fwu; Wu, Chia Chao; Lu, Kuo Cheng.

In: International Journal of Medical Sciences, Vol. 13, No. 3, 20.02.2016, p. 240-247.

Research output: Contribution to journalArticle

Lu, Chien Lin ; Leu, Jyh Gang ; Liu, Wen Chih ; Zheng, Cai Mei ; Lin, Yuh Feng ; Shyu, Jia Fwu ; Wu, Chia Chao ; Lu, Kuo Cheng. / Endothelial progenitor cells predict long-term mortality in hemodialysis patients. In: International Journal of Medical Sciences. 2016 ; Vol. 13, No. 3. pp. 240-247.
@article{52dc5e8d4c4348b0aa613b5c7703d4ab,
title = "Endothelial progenitor cells predict long-term mortality in hemodialysis patients",
abstract = "Background: The endothelial progenitor cells (EPCs) dysfunction is a critical event in the initiation of atherosclerotic plaque development and the level of circulating EPCs can be considered a biomarker of cardiovascular events. The level and functional change in EPCs has been investigated in hemodialysis patients, but the effect of absolute number of EPCs on risk of death has not yet been explored. We hypothesized that the number of EPCs predicted death from cardiovascular and all-cause mortality in hemodialysis patients. Methods: We evaluate the association between endothelial progenitor cells and clinical outcome in 154 patients on maintenance hemodialysis. The blood sample was drawn at the time of patient enrollment and EPCs were identified by flow cytometry using triple staining for CD34/CD133/KDR. Results: The median duration of follow-up was 4.19 years. There were 79 (51.3{\%}) deaths during the follow-up period, 41 of whom died due to a confirmed cardiovascular cause. The cumulative survival was greater in the high-EPC group than the low-EPC group for all-cause and cardiovascular mortality. Decreased EPCs levels were associated with a significant increase in the risk of cardiovascular and all-cause mortality after adjusting for age, gender, current smokers, diabetes mellitus, and hypertension. Conclusions: The level of circulating EPCs independently predicts the clinical outcome in patients on maintenance hemodialysis. Thus, the EPCs levels may be a useful predictive tool for evaluating the risk of death in maintenance hemodialysis patients.",
keywords = "Endothelial progenitor cells, Hemodialysis, Mortality",
author = "Lu, {Chien Lin} and Leu, {Jyh Gang} and Liu, {Wen Chih} and Zheng, {Cai Mei} and Lin, {Yuh Feng} and Shyu, {Jia Fwu} and Wu, {Chia Chao} and Lu, {Kuo Cheng}",
year = "2016",
month = "2",
day = "20",
doi = "10.7150/ijms.14209",
language = "English",
volume = "13",
pages = "240--247",
journal = "International Journal of Medical Sciences",
issn = "1449-1907",
publisher = "Ivyspring International Publisher",
number = "3",

}

TY - JOUR

T1 - Endothelial progenitor cells predict long-term mortality in hemodialysis patients

AU - Lu, Chien Lin

AU - Leu, Jyh Gang

AU - Liu, Wen Chih

AU - Zheng, Cai Mei

AU - Lin, Yuh Feng

AU - Shyu, Jia Fwu

AU - Wu, Chia Chao

AU - Lu, Kuo Cheng

PY - 2016/2/20

Y1 - 2016/2/20

N2 - Background: The endothelial progenitor cells (EPCs) dysfunction is a critical event in the initiation of atherosclerotic plaque development and the level of circulating EPCs can be considered a biomarker of cardiovascular events. The level and functional change in EPCs has been investigated in hemodialysis patients, but the effect of absolute number of EPCs on risk of death has not yet been explored. We hypothesized that the number of EPCs predicted death from cardiovascular and all-cause mortality in hemodialysis patients. Methods: We evaluate the association between endothelial progenitor cells and clinical outcome in 154 patients on maintenance hemodialysis. The blood sample was drawn at the time of patient enrollment and EPCs were identified by flow cytometry using triple staining for CD34/CD133/KDR. Results: The median duration of follow-up was 4.19 years. There were 79 (51.3%) deaths during the follow-up period, 41 of whom died due to a confirmed cardiovascular cause. The cumulative survival was greater in the high-EPC group than the low-EPC group for all-cause and cardiovascular mortality. Decreased EPCs levels were associated with a significant increase in the risk of cardiovascular and all-cause mortality after adjusting for age, gender, current smokers, diabetes mellitus, and hypertension. Conclusions: The level of circulating EPCs independently predicts the clinical outcome in patients on maintenance hemodialysis. Thus, the EPCs levels may be a useful predictive tool for evaluating the risk of death in maintenance hemodialysis patients.

AB - Background: The endothelial progenitor cells (EPCs) dysfunction is a critical event in the initiation of atherosclerotic plaque development and the level of circulating EPCs can be considered a biomarker of cardiovascular events. The level and functional change in EPCs has been investigated in hemodialysis patients, but the effect of absolute number of EPCs on risk of death has not yet been explored. We hypothesized that the number of EPCs predicted death from cardiovascular and all-cause mortality in hemodialysis patients. Methods: We evaluate the association between endothelial progenitor cells and clinical outcome in 154 patients on maintenance hemodialysis. The blood sample was drawn at the time of patient enrollment and EPCs were identified by flow cytometry using triple staining for CD34/CD133/KDR. Results: The median duration of follow-up was 4.19 years. There were 79 (51.3%) deaths during the follow-up period, 41 of whom died due to a confirmed cardiovascular cause. The cumulative survival was greater in the high-EPC group than the low-EPC group for all-cause and cardiovascular mortality. Decreased EPCs levels were associated with a significant increase in the risk of cardiovascular and all-cause mortality after adjusting for age, gender, current smokers, diabetes mellitus, and hypertension. Conclusions: The level of circulating EPCs independently predicts the clinical outcome in patients on maintenance hemodialysis. Thus, the EPCs levels may be a useful predictive tool for evaluating the risk of death in maintenance hemodialysis patients.

KW - Endothelial progenitor cells

KW - Hemodialysis

KW - Mortality

UR - http://www.scopus.com/inward/record.url?scp=84975740645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975740645&partnerID=8YFLogxK

U2 - 10.7150/ijms.14209

DO - 10.7150/ijms.14209

M3 - Article

VL - 13

SP - 240

EP - 247

JO - International Journal of Medical Sciences

JF - International Journal of Medical Sciences

SN - 1449-1907

IS - 3

ER -